The landscape of dementia analysis has advanced substantially with the appearance of refined biomarkers, including amyloid PET scans, tau imaging, and blood-based mostly assessments that can detect Alzheimer's pathology a long time in advance of signs and symptoms emerge. Even though these technological innovations signify impressive development in